Contemporary perspective on endogenous myocardial regeneration

Dejan Milasinovic1, Werner Mohl1

  • 1Dejan Milasinovic, Department of Cardiology, Clinical Centre of Serbia, 11000 Belgrade, Serbia.

Insights

The adult heart has limited self-repair capabilities. This review explores endogenous myocardial regeneration mechanisms and clinical evidence, suggesting developmental pathways could revolutionize heart failure treatment.

Area of Science:

  • Cardiovascular Biology
  • Regenerative Medicine
  • Cardiac Physiology

Background:

  • The adult heart's regenerative capacity is insufficient to repair significant damage.
  • Understanding endogenous repair mechanisms is crucial for treating heart failure.
  • Existing limitations hinder complete myocardial recovery after injury.

Purpose of the Study:

  • To review mechanisms and origins of endogenous myocardial regeneration.
  • To analyze the role of clinical conditions in initiating regeneration.
  • To evaluate clinical studies on stimulating regeneration in failing human hearts.

Main Methods:

  • Examined experimental data on replicating cardiac myocytes and progenitor cells (e.g., c-kit+ cells).
  • Described clinical settings like myocardial ischemia as regenerative pathway initiators.
  • Analyzed clinical trials investigating endogenous regeneration in human heart failure.

Main Results:

  • Identified cardiac progenitor cells and their role in myocyte replication.
  • Demonstrated that ischemia can activate endogenous regenerative pathways.
  • Clinical studies show potential for initiating regeneration in failing hearts.

Conclusions:

  • Endogenous regenerative pathways offer a new therapeutic paradigm for heart failure.
  • Reinitiating developmental pathways (embryonic recall) may enable tissue regeneration.
  • This approach could lead to a paradigm shift in treating dysfunctional myocardium.